Author:
Sreedharan Loveena,Kumar Bhaskar,Jewell Anna,Banim Paul,Koulouris Andreas,Hart Andrew R
Abstract
Pancreatic cancer is the 11th most common cancer in the UK and has the worst prognosis of any tumour with minimal improvements in survival over recent decades. As most patients are either ineligible for surgery or may decline chemotherapy, the emphasis is on control of symptoms and management of complications such as poor nutritional status. The time period between informing the patient of their diagnosis and commencing cancer treatments presents a valuable opportunity to proactively identify and treat symptoms to optimise patients’ overall well-being. The ‘bridging clinic’, delivered by a range of healthcare professionals from gastroenterologists to nurse practitioners, can provide this interface where patients are first informed of their diagnosis and second supportive therapies offered. In this article, we provide a structure for instituting such supportive therapies at the bridging clinic. The components of the clinic are summarised using the mnemonic INDASH (Information/Nutrition/Diabetes and Depression/Analgesia/Stenting/Hereditary) and each is discussed in detail below.
Subject
Gastroenterology,Hepatology
Reference56 articles.
1. cancer research UK, 2018. Pancreatic cancer survival statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer/incidence
2. Globocan. Estimated cancer incidence, mortality and prevalence worldwide in 2012, 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
3. Update on the management of pancreatic cancer: surgery is not enough;Ansari;World J Gastroenterol,2015
4. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
5. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer;Takaori;Pancreatology,2016
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献